HEADER CELL ADHESION, STRUCTURAL PROTEIN 23-MAY-06 2H45 TITLE SOLUTION STRUCTURE OF THE SECOND TYPE III DOMAIN OF HUMAN FIBRONECTIN: TITLE 2 ENSEMBLE OF 25 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBRONECTIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FIBRONECTIN TYPE-III 2(2F3); COMPND 5 SYNONYM: FN, COLD-INSOLUBLE GLOBULIN, CIG; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FN1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-RP; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-2 KEYWDS BETA SANDWICH, CELL ADHESION, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 25 AUTHOR I.VAKONAKIS,I.D.CAMPBELL REVDAT 6 14-JUN-23 2H45 1 REMARK REVDAT 5 26-FEB-20 2H45 1 REMARK SEQADV REVDAT 4 09-JUN-09 2H45 1 REVDAT REVDAT 3 24-FEB-09 2H45 1 VERSN REVDAT 2 20-JAN-09 2H45 1 JRNL REVDAT 1 10-APR-07 2H45 0 JRNL AUTH I.VAKONAKIS,D.STAUNTON,L.M.ROONEY,I.D.CAMPBELL JRNL TITL INTERDOMAIN ASSOCIATION IN FIBRONECTIN: INSIGHT INTO CRYPTIC JRNL TITL 2 SITES AND FIBRILLOGENESIS. JRNL REF EMBO J. V. 26 2575 2007 JRNL REFN ISSN 0261-4189 JRNL PMID 17464288 JRNL DOI 10.1038/SJ.EMBOJ.7601694 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : OMEGA BETA 6.0.3B2, XPLOR-NIH 2.12 REMARK 3 AUTHORS : GE/BRUKER (OMEGA), SCHWIETERS, KUSZEWSKI, TJANDRA, REMARK 3 CLORE NIH/NIDDK/LCP (XPLOR-NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES DERIVED FROM 2827 RESTRAINTS REMARK 4 REMARK 4 2H45 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000037906. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 20MM NACL, 20MM NA2HPO4 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2.5MM 2F3 U-15N, 20MM NAPI PH REMARK 210 7.0, 20MM NACL, 95% H2O, 5% D2O; REMARK 210 2MM 2F3 U-13C,15N, 20MM NAPI PH REMARK 210 7.0, 20MM NACL, 95% H2O, 5% D2O; REMARK 210 2MM 2F3 U-13C,15N, 20MM NAPI PH REMARK 210 7.0, 20MM NACL, 100% D2O; 1MM REMARK 210 2F3 U-15N, 20MM NAPI PH 7.0, REMARK 210 20MM NACL, 4% RADIALLY REMARK 210 COMPRESSED POLYACRYLAMIDE GEL, REMARK 210 95% H2O, 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; HNHA; REMARK 210 4D_13C-SEPARATED_NOESY; HNHB; REMARK 210 15N IPAP-HSQC; C-C LONG RANGE REMARK 210 COUPLINGS; METHYL - CARBONYL REMARK 210 COUPLINGS; METHYL - NITROGEN REMARK 210 COUPLINGS; HACAHB REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : HOME BUILT REMARK 210 SPECTROMETER MANUFACTURER : HOME-BUILT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2.3 REV 2005.319.11.22, REMARK 210 PIPP 4.3.7, XPLOR-NIH 2.12 REMARK 210 METHOD USED : SIMULATED ANNEALING IN CARTESIAN REMARK 210 SPACE REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 25 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 21 HD22 ASN A 62 1.35 REMARK 500 H LEU A 67 OH TYR A 72 1.39 REMARK 500 H SER A 34 O ILE A 79 1.39 REMARK 500 OE2 GLU A 45 HH21 ARG A 70 1.40 REMARK 500 O GLU A 16 HG SER A 21 1.44 REMARK 500 HG SER A 20 O LEU A 66 1.47 REMARK 500 H PHE A 36 O LEU A 54 1.54 REMARK 500 OG SER A 80 OD1 ASP A 82 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 6 -13.79 -160.39 REMARK 500 1 LEU A 7 97.97 -47.47 REMARK 500 1 THR A 10 -97.54 24.18 REMARK 500 1 GLU A 12 103.06 25.79 REMARK 500 1 VAL A 14 53.48 -99.26 REMARK 500 1 GLU A 16 -32.73 -178.72 REMARK 500 1 ILE A 17 -79.58 -19.00 REMARK 500 1 THR A 18 111.35 0.13 REMARK 500 1 SER A 21 -179.44 -65.52 REMARK 500 1 SER A 30 136.53 -172.99 REMARK 500 1 GLU A 44 -73.14 -88.64 REMARK 500 2 VAL A 8 38.04 25.50 REMARK 500 2 THR A 10 -1.39 63.68 REMARK 500 2 SER A 11 -128.08 39.14 REMARK 500 2 GLU A 16 49.10 -66.89 REMARK 500 2 ALA A 19 28.43 36.48 REMARK 500 2 SER A 21 176.54 -59.07 REMARK 500 2 ALA A 29 5.93 43.84 REMARK 500 2 SER A 30 136.30 -176.81 REMARK 500 2 GLU A 44 -65.56 -100.07 REMARK 500 2 ASP A 47 171.01 -48.10 REMARK 500 3 PRO A 2 13.71 -53.72 REMARK 500 3 SER A 5 84.29 64.57 REMARK 500 3 VAL A 8 -78.15 -90.50 REMARK 500 3 ALA A 9 59.42 19.86 REMARK 500 3 GLU A 12 56.08 18.04 REMARK 500 3 SER A 13 -58.24 -14.45 REMARK 500 3 THR A 15 -97.77 -123.19 REMARK 500 3 ILE A 17 6.95 50.04 REMARK 500 3 SER A 28 -0.91 -50.18 REMARK 500 3 ALA A 29 64.14 6.90 REMARK 500 3 SER A 30 -55.77 164.67 REMARK 500 3 ASP A 31 -32.27 77.43 REMARK 500 3 GLU A 44 -75.13 -102.35 REMARK 500 3 ASP A 47 179.34 -52.02 REMARK 500 4 VAL A 8 0.83 -68.76 REMARK 500 4 ALA A 9 39.39 33.15 REMARK 500 4 THR A 10 -38.19 68.24 REMARK 500 4 THR A 15 -98.09 -117.87 REMARK 500 4 GLU A 16 27.98 31.78 REMARK 500 4 ILE A 17 -85.27 -78.52 REMARK 500 4 THR A 18 109.11 7.10 REMARK 500 4 SER A 21 -178.80 -58.34 REMARK 500 4 SER A 30 -36.81 -152.44 REMARK 500 4 ASP A 31 -28.96 67.21 REMARK 500 4 GLU A 44 -63.81 -96.35 REMARK 500 4 ASP A 47 -170.38 -47.70 REMARK 500 5 LEU A 3 -175.28 -47.08 REMARK 500 5 THR A 10 -157.90 -179.08 REMARK 500 5 SER A 11 -171.13 -63.11 REMARK 500 REMARK 500 THIS ENTRY HAS 279 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7127 RELATED DB: BMRB REMARK 900 1H, 13C AND 15N CHEMICAL SHIFT ASSIGNMENTS REMARK 900 RELATED ID: 2H41 RELATED DB: PDB REMARK 900 MINIMIZED AVERAGE STRUCTURE FOR THE SAME PROTEIN DBREF 2H45 A 7 95 UNP P02751 FINC_HUMAN 721 809 SEQADV 2H45 GLY A 1 UNP P02751 CLONING ARTIFACT SEQADV 2H45 PRO A 2 UNP P02751 CLONING ARTIFACT SEQADV 2H45 LEU A 3 UNP P02751 CLONING ARTIFACT SEQADV 2H45 GLY A 4 UNP P02751 CLONING ARTIFACT SEQADV 2H45 SER A 5 UNP P02751 CLONING ARTIFACT SEQADV 2H45 HIS A 6 UNP P02751 CLONING ARTIFACT SEQRES 1 A 95 GLY PRO LEU GLY SER HIS LEU VAL ALA THR SER GLU SER SEQRES 2 A 95 VAL THR GLU ILE THR ALA SER SER PHE VAL VAL SER TRP SEQRES 3 A 95 VAL SER ALA SER ASP THR VAL SER GLY PHE ARG VAL GLU SEQRES 4 A 95 TYR GLU LEU SER GLU GLU GLY ASP GLU PRO GLN TYR LEU SEQRES 5 A 95 ASP LEU PRO SER THR ALA THR SER VAL ASN ILE PRO ASP SEQRES 6 A 95 LEU LEU PRO GLY ARG LYS TYR ILE VAL ASN VAL TYR GLN SEQRES 7 A 95 ILE SER GLU ASP GLY GLU GLN SER LEU ILE LEU SER THR SEQRES 8 A 95 SER GLN THR THR SHEET 1 A 2 PHE A 22 SER A 25 0 SHEET 2 A 2 SER A 60 ILE A 63 -1 O ILE A 63 N PHE A 22 SHEET 1 B 4 GLN A 50 PRO A 55 0 SHEET 2 B 4 VAL A 33 LEU A 42 -1 N PHE A 36 O LEU A 54 SHEET 3 B 4 LYS A 71 SER A 80 -1 O ILE A 79 N SER A 34 SHEET 4 B 4 GLN A 85 THR A 94 -1 O LEU A 89 N VAL A 76 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1